Clinical trial
A Double Blind Placebo Controlled Crossover Pilot Trial of Sativex With Open Label Extension for Treatment of Chemotherapy Induced Neuropathic Pain
NCT00872144 is registered in ClinicalTrials.gov with Mary Lynch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind Placebo Controlled Crossover Pilot Trial of Sativex With Open Label Extension for Treatment of Chemotherapy Induced Neuropathic Pain
- Lead sponsor
- Mary Lynch
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- March 31, 2013
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuropathic pain